Humana Inc. (NYSE:HUM) Given Consensus Recommendation of “Hold” by Brokerages

Humana Inc. (NYSE:HUM) has been given an average rating of “Hold” by the twenty-eight ratings firms that are presently covering the stock, Marketbeat.com reports. Three investment analysts have rated the stock with a sell rating, sixteen have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. The average 12-month target price among brokerages that have issued ratings on the stock in the last year is $296.3913.

A number of research analysts have weighed in on the company. JPMorgan Chase & Co. raised their price target on Humana from $214.00 to $316.00 and gave the company a “neutral” rating in a research note on Monday, June 8th. Barclays increased their price objective on Humana from $180.00 to $344.00 and gave the company an “equal weight” rating in a report on Tuesday, May 26th. Robert W. Baird decreased their target price on shares of Humana from $264.00 to $205.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Bank of America boosted their target price on shares of Humana from $340.00 to $380.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. Finally, Needham & Company LLC started coverage on shares of Humana in a research report on Wednesday, May 20th. They set a “buy” rating on the stock.

Institutional Investors Weigh In On Humana

Several hedge funds have recently bought and sold shares of HUM. Capital International Investors grew its holdings in Humana by 113.9% during the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider’s stock worth $1,490,239,000 after purchasing an additional 3,097,571 shares during the period. Norges Bank acquired a new stake in shares of Humana in the fourth quarter valued at approximately $456,632,000. Pzena Investment Management LLC boosted its stake in shares of Humana by 34.3% during the 1st quarter. Pzena Investment Management LLC now owns 5,470,982 shares of the insurance provider’s stock worth $948,614,000 after acquiring an additional 1,398,774 shares during the period. Wellington Management Group LLP increased its holdings in shares of Humana by 4,481.7% during the 4th quarter. Wellington Management Group LLP now owns 1,196,502 shares of the insurance provider’s stock worth $306,460,000 after acquiring an additional 1,170,387 shares during the last quarter. Finally, Franklin Resources Inc. increased its holdings in shares of Humana by 914.5% during the 4th quarter. Franklin Resources Inc. now owns 1,255,665 shares of the insurance provider’s stock worth $321,613,000 after acquiring an additional 1,131,893 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Price Performance

Shares of NYSE HUM opened at $396.80 on Thursday. The stock has a market capitalization of $47.64 billion, a price-to-earnings ratio of 42.44, a PEG ratio of 2.25 and a beta of 0.71. The business has a 50-day moving average of $332.48 and a 200-day moving average of $253.25. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. Humana has a fifty-two week low of $163.11 and a fifty-two week high of $415.00.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The business had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. During the same quarter in the previous year, the business earned $11.58 earnings per share. Humana’s quarterly revenue was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, sell-side analysts predict that Humana will post 9.03 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. Humana’s payout ratio is currently 37.86%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.